![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 33/00 | (2006.01) |
C01B 21/50 | (2006.01) | ||
A61K 31/17 | (2006.01) | ||
A61K 31/4418 | (2006.01) | ||
A61K 31/4709 | (2006.01) | ||
A61K 31/519 | (2006.01) | ||
A61P 9/00 | (2006.01) | ||
A61P 11/00 | (2006.01) | ||
A61P 17/00 | (2006.01) | ||
A61P 43/00 | (2006.01) |
(11) | Number of the document | 3569237 |
(13) | Kind of document | T |
(96) | European patent application number | 19177863.8 |
Date of filing the European patent application | 2010-02-11 | |
(97) | Date of publication of the European application | 2019-11-20 |
(45) | Date of publication and mention of the grant of the patent | 2021-05-26 |
(46) | Date of publication of the claims translation | 2021-09-10 |
(30) | Number | Date | Country code |
151820 P | 2009-02-11 | US | |
224021 P | 2009-07-08 | US |
(72) |
SHERMAN, Craig, US
LEPINE, Anthony James, US
SMITH, Catherine Marie, US
WIRTZ, Kevin Robert, US
SCHULZE, Erich, US
|
(73) |
Hope Medical Enterprises, Inc. d.b.a. Hope Pharmaceuticals,
16416 N. 92nd Street 125, Scottsdale, AZ 85260,
US
|
(74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Farmacinės kompozicijos, kurių sudėtyje yra natrio nitrito |
SODIUM NITRITE-CONTAINING PHARMACEUTICAL COMPOSITIONS |
Payment date | Validity (years) | Amount | |
2025-01-20 | 16 | 347.00 EUR |
2026-02-11 |